IR@PKUHSC  > 北京大学第三临床医学院
学科主题临床医学
Determination of cilnidipine, a new calcium antagonist, in human plasma using high performance liquid chromatography with tandem mass spectrometric detection
Zhang, Xianhua; Zhai, Suodi; Zhao, Rongsheny; Jin Ouyang; Li, Xiaoquang; Baeyens, Willy R. G.
关键词cilnidipine nimodipine high performance liquid chromatographic method coupled with tandem mass spectrometry (HPLC-MS/MS) human plasma
刊名ANALYTICA CHIMICA ACTA
2007-09-26
DOI10.1016/j.aca.2006.11.072
600期:1-2页:142-146
收录类别ISTP ; SCI
文章类型Proceedings Paper
WOS标题词Science & Technology
类目[WOS]Chemistry, Analytical
研究领域[WOS]Chemistry
关键词[WOS]FELODIPINE ; QUANTIFICATION ; LERCANIDIPINE ; LACIDIPINE ; METABOLITE ; ASSAY
英文摘要

A rapid, sensitive and reliable high performance liquid chromatographic method coupled with tandem mass spectrometry (HPLC-MS/MS) has been developed and validated for the determination of cilnidipine, a relatively new calcium antagonist, in human plasma. The reversed-phase chromatographic system was interfaced with a TurbolonSpray (TIS) source. Nimodipine was employed as the internal standard (IS). Sample extracts following protein precipitation were injected into the HPLC-MS/MS system. The analyte and IS were eluted isocratically on a C18 column, with a mobile phase consisting of CH3OH and NH4Ac (96:4, v/v). The ions were detected by a triple quadrupole mass spectrometric detector in the negative mode. Quantification was performed using multiple reaction monitoring (MRM) of the transitions m/z 491.2 -> 122.1 and m/z 417.1 122.1 for cilnidipine and for the IS, respectively. The analysis time for each run was 3.0 min. The calibration curve fitted well over the concentration range of 0.1-10 ng mL(-1), with the regression equation Y = (0.103 +/- 0.002)X + (0.014 +/- 0.003) (n = 5), r = 0.9994. The intra-day and inter-day R.S.D.% were less than 12.51% at all concentration levels within the calibration range. The recoveries were between 92.71% and 97.64%. The long-term stability and freeze-thaw stability were satisfying at each level. The present method provides a modem, rapid and robust tool for pharmacokinetic studies of cilnidipine. (C) 2006 Elsevier B.V. All rights reserved.

语种英语
WOS记录号WOS:000250457500021
引用统计
被引频次:5[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/59351
专题北京大学第三临床医学院
作者单位1.Peking Univ, TDMCt Ctr, Hosp 3, Beijing 100083, Peoples R China
2.Univ Ghent, Fac Pharmaceut Sci, B-9000 Ghent, Belgium
3.Beijing Normal Univ, Dept Chem, Beijing 100875, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Xianhua,Zhai, Suodi,Zhao, Rongsheny,et al. Determination of cilnidipine, a new calcium antagonist, in human plasma using high performance liquid chromatography with tandem mass spectrometric detection[J]. ANALYTICA CHIMICA ACTA,2007,600(1-2):142-146.
APA Zhang, Xianhua,Zhai, Suodi,Zhao, Rongsheny,Jin Ouyang,Li, Xiaoquang,&Baeyens, Willy R. G..(2007).Determination of cilnidipine, a new calcium antagonist, in human plasma using high performance liquid chromatography with tandem mass spectrometric detection.ANALYTICA CHIMICA ACTA,600(1-2),142-146.
MLA Zhang, Xianhua,et al."Determination of cilnidipine, a new calcium antagonist, in human plasma using high performance liquid chromatography with tandem mass spectrometric detection".ANALYTICA CHIMICA ACTA 600.1-2(2007):142-146.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhang, Xianhua]的文章
[Zhai, Suodi]的文章
[Zhao, Rongsheny]的文章
百度学术
百度学术中相似的文章
[Zhang, Xianhua]的文章
[Zhai, Suodi]的文章
[Zhao, Rongsheny]的文章
必应学术
必应学术中相似的文章
[Zhang, Xianhua]的文章
[Zhai, Suodi]的文章
[Zhao, Rongsheny]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。